The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Paraganglioma: Rare Neuroendocrine Tumor Management

Extra-adrenal chromaffin tumors with hereditary syndromes and specialized perioperative care

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Paraganglioma: Rare Neuroendocrine Tumor Management?

Paragangliomas arise from extra-adrenal chromaffin cells of the autonomic nervous system, distinguished from pheochromocytomas which originate in adrenal medulla.

Anatomic distribution includes head and neck (parasympathetic, often non-functional) and thoracoabdominal (sympathetic, frequently catecholamine-secreting).

Hereditary syndromes account for 30 to 40 percent of cases including SDHB, SDHD, SDHC, VHL, NF1 and RET mutations.

Malignancy risk varies by genotype with SDHB mutations conferring highest risk for metastatic disease.

Diagnosis combines plasma and urinary catecholamine and metanephrine measurement with anatomic and functional imaging.

Symptoms

Classical paroxysmal symptoms of catecholamine excess including headache, palpitations, sweating and pallor in functional tumors.
Sustained or paroxysmal hypertension often resistant to standard antihypertensive therapy.
Head and neck masses presenting as painless cervical or skull base lesions in non-functional tumors.
Symptoms triggered by physical examination, anesthesia induction or specific medications including beta-blockers without prior alpha-blockade.
Asymptomatic tumors discovered incidentally on imaging or during family screening for hereditary syndromes.

Risk Factors

Family history of paraganglioma, pheochromocytoma or hereditary syndromes warrants genetic evaluation.
Known germline mutation in SDHx, VHL, NF1, RET or other paraganglioma susceptibility genes.
Young age at presentation or multifocal disease suggests hereditary etiology.
Chronic hypoxia in residents of high altitude regions associated with carotid body paragangliomas.
Prior history of pheochromocytoma or paraganglioma increases risk of metachronous tumors.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Resistant hypertension with paroxysmal symptoms requires biochemical evaluation for catecholamine-secreting tumor.
  • Newly identified head and neck or abdominal mass with characteristic features warrants endocrine and oncology consultation.
  • Family history of paraganglioma syndromes should prompt genetic counseling and surveillance discussion.
  • Hypertensive crisis during anesthesia or pregnancy in undiagnosed patients requires urgent endocrine evaluation.
  • Long-term follow-up with biochemical and imaging surveillance is essential given recurrence and second tumor risk especially in hereditary cases.

Treatment Methods

01
Complete surgical resection following adequate alpha-adrenergic blockade with phenoxybenzamine or doxazosin is preferred treatment for resectable functional tumors.
02
Beta-blockade is added only after adequate alpha-blockade to prevent hypertensive crisis.
03
Radiation therapy and stereotactic radiosurgery are options for unresectable head and neck tumors and selected metastatic disease.
04
Systemic therapy options for metastatic disease include MIBG-targeted therapy, sunitinib, somatostatin analogs and chemotherapy with cyclophosphamide-vincristine-dacarbazine.
05
Multidisciplinary care, expert anesthesia management, comprehensive genetic counseling, lifelong surveillance and management of treatment-related complications optimize outcomes in these uncommon tumors.

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Paraganglioma

Endokrinoloji

Paragangliomas are neuroendocrine tumors originating from chromaffin tissues outside the adrenal gland, some of which can secrete catecholamines and are often associated with genetic syndromes.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.